Lipoprotein(a), said L-P-little-A, is a genetic cholesterol particle that drives heart attacks and aortic valve narrowing. About 1 in 5 adults carry high levels. It is not on standard cholesterol panels. We test every patient once because the result rarely changes and it shapes lifelong prevention.
Imagine a patient: 45 years old, runs marathons, eats vegan, lean and healthy. They have a massive heart attack on Kelly Drive. The autopsy shows arteries full of plaque despite "normal" cholesterol on every prior panel.
In almost every case like this, the cause is Lipoprotein(a).4
The I-676 metaphor
If your arteries are the Vine Street Expressway (I-676):
- ApoB is the volume of traffic. Too many cars equals traffic jams (plaque).
- Lp(a) is not a normal sedan. It is a Mad Max vehicle with spikes on the wheels.
Even if traffic is light (low ApoB), one Lp(a) car can sideswipe the guardrail, crash into other cars, and start a fire. Because of its sticky tail, it does not just drive past. It digs into the artery wall, drags inflammation with it, and slows the bodys cleanup crew (the clot-dissolving system).
Why do standard labs miss Lp(a)?
Standard labs miss Lp(a) because for decades it was considered untreatable. About 90% of your Lp(a) level is inherited. If your number is high, it was high when you were born and it will be high when you die. Because it does not drop when you eat salad, traditional medicine ignored it for years. The thinking was: if we cannot fix it with diet or meds, why test it?
That logic was wrong. Knowing your Lp(a) changes how we manage every other risk factor.
How do we manage high Lp(a)?
We manage high Lp(a) by lowering the surrounding risk while we wait for new specific drugs to mature. PCSK9 inhibitors like Repatha can lower Lp(a) by about 25 to 30%, and gene-silencing drugs like pelacarsen and olpasiran are in late-stage trials.23 For now, we focus on aggregate risk.
If Lp(a) is a Mad Max car trying to crash, we:
- Clear the road: We drive your standard ApoB values down to about 30 to 40 mg/dL with statins, ezetimibe, or PCSK9 inhibitors. PCSK9 inhibitors have the bonus of lowering both ApoB and Lp(a).
- Install guardrails: We control blood pressure (target around 120/80) and blood sugar tighter than average to protect the artery wall.
- Daily low-dose aspirin (when appropriate): To counter the clotting risk that Lp(a) raises. We discuss bleeding risk first.
- Image early: A CT Coronary Angiogram (CTA) with Cleerly AI in your 40s tells us if Lp(a) is already laying down soft plaque, so we can match treatment intensity to the actual disease.
Actionable Steps in Philly
Take the genetic test that changes prevention for life.
- Ask for Lp(a) by name at your next blood draw. Cash price is usually about $40.
- Treat above 75 nmol/L (or 30 mg/dL) as a real risk signal. Above 125 nmol/L (or 50 mg/dL) is high risk.
- Lower ApoB to under 60 mg/dL if your Lp(a) is high.
- Cascade test your relatives. Each first-degree relative has a 50% chance of carrying it.
Key Takeaways
- Test Once: Levels stay stable for life. You only need to check this once.
- Family Risk: If you have it, your siblings and children each have a 50% chance of having it. Cascade screening saves lives.
- Aortic Stenosis: High Lp(a) also calcifies the aortic heart valve. We listen carefully for murmurs and order imaging when indicated.1
Scientific References
- Kronenberg F, et al. "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement." European Heart Journal. 2022.
- Tsimikas S, et al. "Lipoprotein(a) Reduction in Persons with Cardiovascular Disease." New England Journal of Medicine. 2020.
- O'Donoghue ML, et al. "Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease." New England Journal of Medicine. 2022.
- Reyes-Soffer G, et al. "Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease." Arteriosclerosis, Thrombosis, and Vascular Biology. 2022.
Related Articles:
Dr. Ash is a board-certified internal medicine physician at Fishtown Medicine in Philadelphia. He practices advanced preventive cardiology with a focus on identifying and managing genetic cardiovascular risk early.
Related at Fishtown Medicine
- Borderline Cholesterol: How ApoB, Lp(a), and Blood Pressure Change the Plan - a patient case where 3 unmeasured numbers turned "recheck in a year" into a plan
- Stroke Prevention in Philadelphia - the 2024 AHA/ASA guideline applied across BP, GLP-1, diet, CRF, and insulin resistance
- ApoB and Heart Health - the cholesterol particle count that predicts heart attacks far better than standard LDL
- Lp(a) and Cholesterol - why you can have perfect cholesterol and still be at high risk
- ED and Cardiovascular Risk - erectile dysfunction as the earliest warning sign of vascular disease
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.
